EUVIMEDEUVIMED entdecken
Crossref

Bone marrow findings post allogeneic transplant for myeloproliferative neoplasms and chronic myelomonocytic leukemia with increased fibrosis

Srishti Gupta, Elizabeth L Courville

Laboratory Medicine · 2024

DOI: 10.1093/labmed/lmae018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, 2024. Verfasst von Srishti Gupta und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Virginia School of Medicine and University of Virginia Health System, Charlottesville, VA, US. Hauptthemen laut MEDLINE: Bone Marrow, Leukemia, Myelomonocytic, Chronic, Myeloproliferative Disorders. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allogeneic hematopoietic stem cell transplant for myeloid neoplasms with increased fibrosis is uncommon; morphologic features posttransplant can be concerning for persistent disease.

Methods

In this retrospective study, we identified 22 patients transplanted for myeloproliferative neoplasms or chronic myelomonocytic leukemia with fibrosis at our institution, and reviewed slides from pretransplant and posttransplant bone marrow biopsies. Clinical features and results of molecular, chimerism, and cytogenetic studies were retrieved from the medical record.

Results

Pretransplant bone marrow biopsies commonly exhibited hypercellularity, atypical megakaryocytes, and reticulin fibrosis. At day 100, 36% of biopsies had reticulin grade >MF1 and 33% of those tested had positive molecular studies, with no significant associations between day 100 marrow characteristics and molecular profile or peripheral count recovery times. In the 1 year posttransplant biopsies (n = 12), 7 of 9 had negative molecular studies; of these, none had reticulin grade >MF1, 1 had trichrome 1+, 2 had atypical megakaryocytes, and 1 was hypercellular.

Conclusions

Supporting recent literature, our study indicates that persistent day 100 reticulin fibrosis/collagen deposition does not show an association with day 100 molecular status. Our study additionally provides data for 12 patients with 1 year posttransplant marrow biopsies, with the majority of those lacking either increased fibrosis or molecular evidence of persistent disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone MarrowLeukemia, Myelomonocytic, ChronicMyeloproliferative DisordersHumansRetrospective StudiesMaleMiddle AgedFemaleAdultAgedHematopoietic Stem Cell TransplantationFibrosisBiopsyTransplantation, HomologousPrimary Myelofibrosis

Stichwörter der Autor:innen

allogeneic stem cell transplantmolecularmyelofibrosisposttransplantremission

Autor:innen und Institutionen

  • University of Virginia School of Medicine and University of Virginia Health System, Charlottesville, VA, US.

Zitieren

APA

Gupta, S., & Courville, E. L. (2024). Bone marrow findings post allogeneic transplant for myeloproliferative neoplasms and chronic myelomonocytic leukemia with increased fibrosis. Laboratory Medicine. https://doi.org/10.1093/labmed/lmae018

Vancouver

Gupta S, Courville EL. Bone marrow findings post allogeneic transplant for myeloproliferative neoplasms and chronic myelomonocytic leukemia with increased fibrosis. Laboratory Medicine. 2024. doi:10.1093/labmed/lmae018

BibTeX
@article{Gupta2024,
  author = {Gupta, Srishti and Courville, Elizabeth L},
  title = {Bone marrow findings post allogeneic transplant for myeloproliferative neoplasms and chronic myelomonocytic leukemia with increased fibrosis},
  journal = {Laboratory Medicine},
  year = {2024},
  doi = {10.1093/labmed/lmae018}
}
Kostenlos starten →